Publication:
Closed‐looped stimulation cardiac pacing for recurrent vasovagal syncope: A systematic review and meta‐analysis

dc.contributor.authorPattara Rattanawongen_US
dc.contributor.authorTanawan Riangwiwaten_US
dc.contributor.authorPakawat Chongsathidkieten_US
dc.contributor.authorWasawat Vutthikraiviten_US
dc.contributor.authorNath Limpruttidhamen_US
dc.contributor.authorNarut Prasitlumkumen_US
dc.contributor.authorNapatt Kanjanahattakijen_US
dc.contributor.authorChanavuth Kanitsoraphanen_US
dc.contributor.otherDuke University Medical Centeren_US
dc.contributor.otherTexas Tech University Health Sciences Center at Lubbocken_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherUniversity of Hawaii at Manoaen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherEinstein Medical Centeren_US
dc.date.accessioned2019-08-28T06:38:57Z
dc.date.available2019-08-28T06:38:57Z
dc.date.issued2018-01-01en_US
dc.description.abstract© 2018 The Authors. Background: Vasovagal syncope (VVS) is defined by transient loss of consciousness with spontaneous rapid recovery. Recently, a closed‐loop stimulation pacing system (CLS) has shown superior effectiveness to conventional pacing in refractory VVS. However, systematic review and meta‐analysis has not been performed. We assessed the impact of CLS implantation and reduction in recurrent VVS events by a systematic review and a meta‐analysis. Methods: We comprehensively searched the databases of MEDLINE and EMBASE from inception to September 2017. Included studies were published prospective or retrospective cohort, randomized controlled trial, and case–control studies that compared VVS events between recurrent, severe, or refractory cardioinhibitory VVS patient implanted with CLS and conventional pacing. Data from each study were combined using the random‐effects, generic inverse variance method of DerSimonian and Laird to calculate odds ratios and 95% confidence intervals. Results: Six studies from November 2004 to October 2017 were included in this meta-analysis involving 224 recurrent, severe, or refractory cardioinhibitory VVS patients implanted with CLS and 163 recurrent, severe, or refractory VVS patients implanted with conventional pacing. CLS significantly reduced recurrent VVS events compared to conventional pacing (pooled odds ratio = 0.23, 95% confidence interval: 0.13‐0.39, P = 0.000, I 2 = 36.5%) as well as subgroup of four randomized controlled trial studies (pooled odds ratio = 0.28, 95% confidence interval: 0.17‐0.44, P = 0.000, I 2 = 39.2%). Conclusion: Closed‐loop stimulation significantly reduced recurrent VVS events up to 80% when compared to conventional pacing. Our study suggests that CLS is an effective tool for preventing syncope recurrences in patients with recurrent, severe, or refractory cardioinhibitory VVS.en_US
dc.identifier.citationJournal of Arrhythmia. Vol.34, No.5 (2018), 556-564en_US
dc.identifier.doi10.1002/joa3.12102en_US
dc.identifier.issn18832148en_US
dc.identifier.issn18804276en_US
dc.identifier.other2-s2.0-85052474593en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/47224
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052474593&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleClosed‐looped stimulation cardiac pacing for recurrent vasovagal syncope: A systematic review and meta‐analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85052474593&origin=inwarden_US

Files

Collections